|
Diaceutics PLC - UK testing laboratories company - Announces ‘significant enhancements’ to its DXRX platform in order to improve user experience. Company says customers will now be able to access three new AI-powered tools to ensure medicines get to patients quicker.
‘This is an important new release for our customers, allowing a greater level of self service and flexibility when using the DXRX platform,’ says Scott Gamester, vice president of Data & Platform at Diaceutics.
Current stock price: 107.00 pence
12-month change: down 14%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
